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ABSTRACT
Background: Both genetic and environmental factors affect the risk
of colorectal cancer (CRC).
Objective: We aimed to examine the interaction between the
D1822V polymorphism of the APC gene and dietary intake in per-
sons with CRC.
Design: Persons with CRC (n  196) and 200 healthy volunteers,
matched for age and sex in a case-control study, were evaluated with
respect to nutritional status and lifestyle factors and for the D1822V
polymorphism.
Results: No significant differences were observed in energy and
macronutrient intakes. Cases had significantly (P  0.05) lower
intakes of carotenes, vitamins C and E, folate, and calcium than did
controls. Fiber intake was significantly (P  0.004) lower in cases
than in controls, whereas alcohol consumption was associated with
a 2-fold risk of CRC. In addition, cases were significantly (P 
0.001) more likely than were controls to be sedentary. The homozy-
gous variant for the APC gene (VV) was found in 4.6% of cases and
in 3.5% of controls. Examination of the potential interactions be-
tween diet and genotype found that a high cholesterol intake was
associated with a greater risk of colorectal cancer only in noncarriers
(DD) of the D1822V APC allele (odds ratio: 1.66; 95% CI: 1.00,
2.76). In contrast, high fiber and calcium intakes were more mark-
edly associated with a lower risk of CRC in patients carrying the
polymorphic allele (DV/VV) (odds ratio: 0.50; 95% CI: 0.27, 0.94 for
fiber; odds ratio: 0.51; 95% CI: 0.28, 0.93 for calcium) than in those
without that allele.
Conclusion: These results suggest a significant interaction between
the D1822V polymorphism and the dietary intakes of cholesterol,
calcium, and fiber for CRC risk. Am J Clin Nutr 2007;85:
1592–7.
KEY WORDS Colorectal cancer, diet, genetic polymorphism,
lifestyle factors
INTRODUCTION
Colorectal cancer (CRC) is a major cause of cancer mortality
in industrialized countries that have adopted a Western type of
diet (1). Both environmental and genetic factors have been im-
plicated in the occurrence of CRC (2). Of environmental factors,
obesity, a lack of physical activity, high energy intake, and a diet
rich in red meat and poor in protective factors such as fruit and
vegetables have consistently been associated with a greater risk
of CRC (3, 4).
However, different studies show conflicting results with re-
spect to the factors that protect from and those that promote CRC:
although most case-control studies support the abovementioned
associations (5), the results obtained in prospective, interven-
tional studies are less clear-cut. The reasons for these discrepan-
cies may relate to recall bias, which occurs in case-control studies
because, in a disease such as cancer, dietary intake in the more
distant past may be more relevant but more difficult to recall (6).
Moreover, in an assessment of cancer risk, there are complex
dietary interactions that occur not only between nutrients but also
with other variables, such as smoking and drinking habits, exer-
cise or body composition, or both, that confound the analysis of
a single nutrient. In their review, Marques-Vidal et al (5) ob-
served that the isolated consumption of either vegetables or fruit
conferred no protection in most of the studies analyzed, whereas
the combined consumption of both of these foodstuffs was
protective.
Moreover, these dietary relations are further complicated by
interactions with genetic factors. This genetic heterogeneity of
the studied population may explain why different persons re-
spond differently to similar nutritional stimuli. A difference in
susceptibility is usually due to the presence of single-nucleotide
polymorphisms (SNPs), which consist of mutations in single
DNA bases. These SNPs do not always affect protein function
but may account for variations such as greater protection from or
susceptibility to a certain disease, especially in conjunction with
environmental stimuli such as dietary intake (7).
With respect to CRC, a polymorphism in the APC gene (Ad-
enomatous polyposis coli) has been studied that, when correlated
with nutritional factors, may influence the risk of CRC. This
polymorphism is characterized by a substitution of an adenine
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base for a thymidine base in codon 1822, which results in a
substitution of an aspartate base for a valine base (GAC3GTC)
(8). The interaction between dietary habits and this polymor-
phism in CRC development has been examined in 2 studies, but
the examination for nutritional correlates was restricted to fat
intake (9, 10). The aim of the present study was to assess the
interaction between the D1822V polymorphism in the APC gene
and dietary intake in a group of Portuguese CRC patients.
SUBJECTS AND METHODS
Subjects
This was a case-control study, performed at the Instituto Por-
tugueˆs de Oncologia de Lisboa Francisco Gentil EPE (IPOLFG).
The group with cancer (ie, cases) was composed of 196 subjects
(104 M, 92 F; x  SD age: 64.2  11.3 y) with a histologic
diagnosis of CRC, and the control group included 200 healthy
blood donors and health care workers recruited from IPOLFG,
with a similar sex and age distribution (106 M, 94 F; age 62.2
12.1 y) and no history of cancer at any site. Of the cases, 169 of
196 (86.5%) had a recent diagnosis of CRC, and the remaining 27
(13.5%) were being treated for a disease relapse. With respect to
previous therapies, 119 of 196 (60.7%) had not received any form
of treatment, 28 of 196 (14.3%) had already undergone surgery,
13 of 196 (6.6%) had had pelvic radiotherapy, 11 of 196 (5.6%)
had received 1 cycles of chemotherapy, and the 25 of 196
(12.8%) had undergone combined forms of treatment. TNM
staging was as follows: stage I, 24 of 178 (13.5%); stage II, 64 of
178 (35.9%); stage III, 53 of 178 (29.8%); and stage IV, 37 of 178
(20.8%).
All subjects gave written informed consent. The study was
approved by the Scientific Ethics Committee of the IPOLFG.
Data collection
Dietary assessment was performed by using a food-frequency
questionnaire (11), which was validated for the Portuguese pop-
ulation. Participants were asked to recall their habits in the year
before CRC diagnosis (cases) or in the year before interview
(controls). The type and quantity of food intake were then ana-
lyzed in a modified database FOOD PROCESSOR software
(version 7; Esha Research, Inc, Salem, OR) including some Por-
tuguese food items, which allows the quantification of different
macronutrients and micronutrients. Physical activity in the year
before cancer diagnosis (cases) or in the year before interview
(controls) was assessed by using the questionnaire of Arroll et al
(12), which groups subjects in 3 categories: low (0), intermediate
(1), and high (2) activity. Smoking habits were recorded as the
number of cigarettes smoked per day. For calculation of the body
mass index (BMI; in kg/m2), we used a digital scale (SECA,
Hanover, MD) that was accurate to0.1 kg and the height that
had been recorded in the participants’ government identity cards.
Genotype data
Whole blood samples were collected and stored in 3-mm
Cards Kit papers. DNA extraction was done by using a Genera-
tion Capture Card Kit–DNA Purification; DNA Elution (all:
Gentra Systems Inc, Minneapolis, MN). The GAC3GTC poly-
morphism at codon 1822 of the APC gene was genotyped by
using an Assays-by-Design TaqMan allelic discrimination assay
(Applied Biosystems, Foster City, CA). Polymerase chain reac-
tion (PCR) was carried out with mixes consisting of 4 L
genomic DNA, 10L Taqman Universal PCR Master Mix (Ap-
plied Biosystems,), 1 L of 20 assay mix, and ddH2O up to
20L of final volume. The following amplification protocol was
used: denaturation at 95 °C for 10 min, 40 cycles of denaturation
at 92 °C for 15 s, and annealing and extension at 60 °C for 1 min.
All of the reactions were performed in the iCycler iQ Multi-
color Real Time PCR Detection System (Bio-Rad, Hercules,
CA). After PCR, the genotype of each sample was attributed
automatically by measuring the allele-specific fluorescence on
the equipment software. Subjects were classified as homozygous
for the variant if they carried both valine and valine (VV) alleles,
heterozygous if they had the aspartate and valine (DV) genotype,
and homozygous wild-type if they had the aspartate and aspartate
(DD) genotype.
Statistical analysis
Statistical analysis was performed by using SPSS for WIN-
DOWS software (version 12.0; SPSS Inc, Chicago, IL). Data
were expressed as means SDs, as the number (and percentage)
of subjects, and as odds ratio (OR) and 95% CIs. Bivariate anal-
yses were conducted by using Student’s t test or the Mann-
Whitney test for continuous variables and the chi-square test for
categorical variables. Multiple logistic regression was used to
estimate associations by using ORs and 95% CIs. Briefly, dietary
habits were categorized as high or low for intake above or below
the median values, respectively, and 4 independent groups were
created according to D1822V APC and diet. Risk was assessed by
examining the combined effects of the D1822V genotype and
diet, using as the referent category (ie, standard risk) those with
low dietary intake and no variant for APC gene. The remaining 3
groups were no variant and high intake, with variant (DV or VV)
and low intake, and with variant and high intake. Those groups
were then included in the logistic regression to assess their rela-
tions with risk of CRC; further adjustment on other variables was
performed whenever necessary. Statistical significance was es-
tablished for P 0.05.
RESULTS
Lifestyle habits, family history, weight, and BMI for both
study groups are shown in Table 1. With respect to physical
activity, cases had lower levels of intense activity before cancer
diagnosis than after, but exercise per se did not influence the risk
of developing CRC (OR: 0.78; 95% CI: 0.53, 1.1). Moreover, no
differences in smoking habit were found between groups. With
respect to alcohol intake, we observed that 35.8% of patients and
38.5% controls did not consume any alcohol. Of the subjects who
drank alcohol, cases had a significantly higher alcohol than did
controls (38.8 g/d compared with 31.0 g/d; OR: 1.97; 95% CI:
1.19, 3.26). Familial history of CRC in first- or second-degree
relatives was also greater in CRC subjects than in controls (OR:
3.4; 95% CI: 1.85, 6.29). With respect to nutritional assessment,
we observed that both weight and BMI were significantly lower
in cases than in controls (Table 1).
Daily energy and macronutrient intakes are shown in Table 2.
No significant differences in macronutrient consumption were
observed between cases and controls. However, we observed a
significantly lower intake of fiber in cases than in controls: those
with a daily intake higher than the median (25.6 g) had an OR of
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0.58 (95% CI: 0.4, 0.8) for CRC development compared with
those who consumed less than the median.
Micronutrient intake in both study groups—including supple-
mental intake, which occurred in 11 cases and no controls—is
shown in Table 3. We observed that cases had a significantly
lower intake of carotenes, vitamin C, vitamin E, folate, and cal-
cium than did controls. For these micronutrients, ORs were cal-
culated considering intake above or below the median.
No significant differences in genotype distribution were ob-
served, and both groups were found to be in Hardy-Weinberg
equilibrium. Homozygotes for the variant made up 4.6% of cases
and 3.5% of controls, whereas heterozygotes made up 30.1% and
33% of cases and controls, respectively. In the cases only, we
observed no correlation between genotype and sex, tumor loca-
tion, stage of disease, or familial history of CRC. The interaction
between intake of several macronutrients and micronutrients and
APC genotype is shown in Table 4. To increase statistical power,
risk was assessed by combining the heterozygotes and variant
homozygotes against the reference category of homozygosity for
the wild-type allele. Significant associations were observed be-
tween genotype and cholesterol (P 0.05), fiber (P 0.03), and
calcium (P  0.03) intakes. A high intake of cholesterol was
associated with a significantly (P 0.05) greater risk of devel-
oping CRC only in wild-type (DD) carriers, whereas high intakes
of fiber and calcium decreased the risk of developing CRC by
nearly 50% in cases with the polymorphic alleles (DV and VV).
Separate consideration of the 3 genotypes resulted in somewhat
different P values for interaction, but the fundamental interaction
between APC genotype and fat, calcium, and fiber intakes still
held true.
DISCUSSION
Numerous studies have examined the relation between diet,
lifestyle habits, and genetic traits and the prevalence of CRC, and
the results obtained have varied widely. The present study was
aimed at correlating dietary intake with the D1822V polymor-
phism in the APC gene in a group of Portuguese subjects. Al-
though this missense mutation does not theoretically affect pro-
tein function, it may result in slight conformational alterations
that may interact with environmental factors, thereby influencing
the risk of developing CRC.
We observed that the proportion of subjects with intense phys-
ical activity was lower among the cases than among the controls.
However, in contrast to previous studies (13, 14), we did not
observe that smokers were at higher risk of CRC. The latter
finding may be related to the fact that the present study had a
smaller sample than did previous studies. Analysis of alcohol
intake showed that daily consumption 28.9 g alcohol/d
nearly doubled the risk of CRC. In this respect, the literature
is somewhat confusing, because some studies have reported a
promoting effect of alcohol intake (15), although others have
not (16), and still others have found a promoting effect only
for rectal cancer (17).
Assessment of nutritional status found that cases had a BMI
lower than that of controls. As stated before, this evaluation was
performed after disease diagnosis, and 40% of patients had al-
ready undergone some form of medical or surgical treatment (or
both). It is plausible, therefore, that complaints related to CRC or
its treatment (or both) may have had a negative effect on the
nutritional status of some patients. Kune et al (18) reported find-
ings similar to our own with respect to BMI: in a large case-
control study involving 715 cases matched to 727 controls, they
did not find that excess of body weight was a risk factor for CRC.
This is in contrast to several prospective studies that found in-
creased BMI to be a risk factor for CRC (19, 20); in those studies,
excess body weight was detected long before diagnosis or treat-
ment (or both) took place.
No differences in macronutrient intake were present, but sig-
nificant differences were observed with respect to the intake of
micronutrients. We found that intakes of carotenes, vitamin C,
vitamin E, folate, calcium, and fiber were significantly lower in
cases than in controls. OR calculations showed a significant
protective effect for fiber, calcium, and carotenes. Most studies
TABLE 1






Low [n (%)] 106 (54.1) 96 (48.0) —
Intermediate [n (%)] 78 (39.8) 66 (33.0) —
High [n (%)] 12 (6.1) 38 (19.0) 0.0013
Smoker [n (%)] 24 (12.2) 26 (13.0) NS
Cigarettes (no./d)3 7.0 12.44 7.9 13.6 NS
Drinker [n (%)] 127 (64.8) 123 (61.5) NS
Ethanol (g/d) 25.2 39.8 19.2 43.4 NS
Familial CRC history
[n (%)]5
45 (23) 16 (8) 0.001
Height (m) 1.63 0.09 1.64 0.09 NS
Weight (kg) 68.5 13.9 72.3 12.1 0.004
BMI (kg/m2) 25.6 4.2 27.0 3.9 0.01
1 CRC, colorectal cancer. For Physical activity, drinkers, smokers, and
familial CRC history, a chi-square test was used for statistical analysis;
differences in ethanol intake were analyzed by using the Mann-Whitney U
test; and differences in height, weight, and BMI between groups were ana-
lyzed by using Student’s t test.
2 Classified according to the questionnaire of Arroll et al (12).
3 The prevalence of high physical activity was significantly greater in
controls than in cases.
4 x  SD (all such values).
5 CRC in first- or second-degree relative.
TABLE 2





Energy (kcal) 3113 1178 2938 1015 NS
Proteins (g) 133.5 57.6 130.3 50.4 NS
Carbohydrates (g) 285.6 86.1 290.0 95 NS
Total fat (g) 134.0 77.7 130.0 95 NS
Polyunsaturated fat (g) 21.2 12.1 19.9 9.5 NS
Monounsaturated fat (g) 54.5 28.5 54.5 25.0 NS
Saturated fat (g) 47.6 34.4 45.3 30.9 NS
Total cholesterol (mg) 507 304.7 460 250.3 NS
Fiber (g) 26.0 9.3 28.9 10.7 0.004
1 All values are x  SD.
2 The Mann-Whitney U test was used to analyze differences between
groups.
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are consistent with our observations on calcium intake, finding a
protective effect of calcium intake against adenoma recurrence
(21) and against the development of CRC (22). In a meta-analysis
involving 10 studies aimed at examining the effect of calcium
intake on CRC risk, Eunyoung et al (23) observed that an intake
of1100 mg Ca/d reduces the risk of developing CRC by 25%
(OR: 0.74; 95% CI: 0.62, 0.88). In the present study, we observed
a 40% reduction in the risk of developing CRC for those con-
suming1029 mg Ca/d.
The protective effect of antioxidants against colorectal carci-
nogenesis has been shown by some (24, 25) but not all (26)
studies. The same applies to the protective effect of fiber that was
observed in this study: our results are consistent with those of
most case-control studies (27, 28), but they diverge from the
results presented in prospective studies (29–31). These discrep-
ancies may be related to the facts that the source of these nutrients
are fruit and vegetables and that analysis of the isolated effect of
a single nutrient might be misleading. This hypothesis is further
supported by a recent review (5) in which the authors observed
that consumption of both fruit and vegetables exerts a protective
effect stronger than that of separate consumption of each of these
foods.
Regarding the polymorphism of APC gene, the percentage of
heterozygotes, wild types, and homozygous variants was similar
between the cancer and control groups, which is also similar to 2
previously published studies (9, 10). This finding allows us to
conclude that the polymorphism per se does not modify the risk
of developing CRC. Some interesting results were observed with
regard to the interaction between nutritional and genetic factors.
To our knowledge, only 2 previous studies examined the inter-
action between this polymorphism, nutrition, and the risk of CRC
(9, 10). Slattery et al (9) observed that persons who were ho-
mozygous for this variant were at lower risk if they consumed a
low-fat diet (OR: 0.2; 95% CI: 0.1, 0.5). In another study, Me-
nendez et al (10) did not observe any interaction between nutri-
ents and the polymorphic allele. In the present study, we ob-
served that a high intake of cholesterol resulted in a higher risk of
CRC development only in subjects who were homozygous for
the wild-type allele (DD). This promotor effect was not observed
in carriers of the polymorphic allele. Moreover, we observed that
fiber and calcium intakes were mainly protective [OR: 0.50
(0.27, 0.94); OR: 0.51 (0.28, 0.93), respectively] for both het-
erozygous and homozygous carriers of the mutated allele. Nei-
ther of the 2 previous studies found any significant interaction
with any nutrient besides fat.
At this moment, we can only speculate on possible mecha-
nisms through which fat, calcium, or fiber intake can interact
with APC polymorphism to modify the risk of CRC develop-
ment. APC is a multifunctional protein, although its main tumor
suppressor function appears to reside in the capacity to down-
regulate -catenin in the WNT signaling pathway. In the pres-
ence of APC-truncating mutations, -catenin cannot be phos-
phorylated; it accumulates in the cytoplasm, from which it
translocates to the nucleus, which leads to the activation of WNT
target genes (32). Thus far, only 2 missence variants of the APC
gene—ie, I1307K and E1317Q variants—have been associated
with increased risk of CRC, although the association with the
latter is still controversial (33). Although missense variants in the
APC gene are not potentially pathogenic, so far nothing has been
reported for the D1822V variant. Thus, we cannot exclude the
possibility that this amino acid alteration located between the 4th
and the 5th-catenin down-regulating domain may induce some
conformational alterations in the APC protein that may lead to a
slightly less efficient -catenin down-regulation. One can hy-
pothesize that the presence of this variant is not in itself sufficient
for tumor initiation. However, in the presence of dietary factors
TABLE 3




(n 200) P2 OR (95% CI)3
Vitamin A (g) 944.8 890.0 925.4 644 NS ND
Carotenes (g) 985.5 59.9 1264.5 1128.3 0.02 0.67 (0.44, 0.99)4
Vitamin C (mg) 144.9 60 168.4 74.8 0.001 0.56 (0.38, 0.84)4
Vitamin D (g) 7.01 4.7 7.2 4.7 NS ND
Vitamin E (mg) 10.8 4.4 11.9 5.1 0.03 0.75 (0.5, 1.1)
Vitamin K (g) 4353.8 1363.7 4408.6 1335.7 NS ND
Folate (g) 401.6 161.9 433.4 162.0 0.02 0.72 (0.49, 1.1)
Vitamin B-6 (mg) 2.83 1.06 2.85 0.98 NS ND
Vitamin B-12 (g) 14.54 9.05 14.3 8.21 NS ND
Sodium (mg) 3961.9 2847.3 3662.43 2282.3 NS ND
Potassium (mg) 4353.8 1363.7 4408.6 1335.7 NS ND
Magnesium (mg) 416.6 134.9 428.5 131.1 NS ND
Selenium (mg) 144.5 56.3 143.5 53.6 NS ND
Iron (mg) 22.2 9.8 21.8 8.7 NS ND
Calcium (mg) 1029.3 410.7 1181.3 626.4 0.01 0.59 (0.49, 0.88)4
1 All values are x  SD. OR, odds ratio; ND, not determined.
2 The Mann-Whitney U test was used to analyze differences between groups.
3 ORs were determined by using the values above or below median nutrient intake. Reference category—ie, standard risk for colorectal cancer—was
considered a combination of the wild-type genotype and low intakes of several micronutrients. Cutoffs were 873.4 g for carotenes, 147.5 mg for vitamin C,
10.3 mg for vitamin E, 406.7 g for folate, and 1029 mg for calcium.
4 P 0.05.
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that are cancer promotors (eg, high fat intake), it may result in
higher production of diacylglycerol. High concentrations of di-
acylglycerol promote a higher activation of protein kinase C,
which can activate to a higher degree the WNT pathway, thereby
promoting cancer growth.
In the present study, we also showed that carriers of the mu-
tated allele benefited the most from a high calcium intake. It is
known that APC protein also interacts with the transmembranar
protein, E-cadherin, another cellular adhesion molecule (34).
Because E-cadherin is a calcium-dependent protein, we can
TABLE 4
















High 54/62 27/37 1.29 (0.78, 2.12) 0.90 (0.48, 1.68) 0.21
Low 74/65 41/36 1 1.20 (0.67, 2.16)
Protein
High 73/59 26/37 1.57 (0.95, 2.60) 0.91 (0.49, 1.71) 0.24
Low 55/68 42/36 1 1.42 (0.79, 2.56)
Carbohydrates
High 69/67 26/35 1.15 (0.70, 1.90) 0.91 (0.48, 1.71) 0.50
Low 59/60 42/38 1 1.06 (0.59, 1.89)
Total fat
High 72/61 23/42 1.37 (0.83, 2.27) 0.69 (0.37, 1.3) 0.12
Low 56/66 45/31 1 1.59 (0.89, 2.88)
Saturated fat
High 72/62 23/41 1.28 (0.78, 2.12) 0.67 (0.36, 1.26) 0.17
Low 56/65 45/32 1 1.51 (0.84, 2.73)
Polyunsaturated fat
High 76/63 21/38 1.48 (0.89, 2.45) 0.74 (0.38, 1.42) 0.14
Low 52/64 47/35 1 1.55 (0.87, 2.78)
Monounsaturated fat
High 72/61 27/38 1.40 (0.85, 2.32) 0.89 (0.48, 1.66) 0.10
Low 56/66 41/35 1 1.31 (0.73, 2.35)
Total cholesterol
High 77/60 26/35 1.66 (1.0, 2.76) 1.00 (0.53, 1.89) 0.05
Low 51/67 42/38 1 1.40 (0.78, 2.50)
Fiber
High 61/73 23/41 0.7 (0.43, 1.16) 0.50 (0.27, 0.94) 0.03
Low 67/54 45/32 1 1.08 (0.60, 1.95)
Alcohol
High 65/62 35/36 1.14 (0.69, 1.88) 1.06 (0.58, 1.91) 0.96
Low 63/65 33/37 1 0.90 (0.50, 1.65)
Folate
High 61/66 27/44 0.90 (0.54, 1.48) 0.60 (0.33, 1.09) 0.13
Low 67/61 41/29 1 1.28 (0.70, 2.32)
Vitamin B-6
High 66/64 26/41 0.99 (0.59, 1.62) 0.66 (0.35, 1.21) 0.16
Low 62/63 42/32 1 1.23 (0.67, 2.24)
Vitamin B-12
High 72/62 26/38 1.35 (0.82, 2.22) 0.85 (0.45, 1.58) 0.09
Low 56/65 42/35 1 1.31 (0.73, 2.35)
Calcium
High 59/69 26/44 0.74 (0.45, 1.21) 0.51 (0.28, 0.93) 0.03
Low 69/58 42/29 1 1.21 (0.66, 2.20)
1 n 128 cases without variant; n 127 controls without variant, n 68 cases with variant, n 73 controls with variant.
2 ORs were estimated by examining the combined effect of D1822V genotype and dietary intake by using the values above or below the median nutrient
intake. The cutoffs were 2827 for kcal, 121.1 g for protein, 270 g for carbohydrates, 110.9 g for total fat, 32.7 g for saturated fat, 48.3 g for monounsaturated
fat, 17.6 g for polyunsaturated fat, 404 mg for cholesterol, 25.6 g for fiber, 3.4 g/d for alcohol, 12.5 g for vitamin B-12, 406.7 g for folate, and 12.5 mg for
vitamin B-12. Reference category—ie, standard risk for colorectal cancer—was considered a combination of the wild-type genotype and low intakes of several
micronutrients.
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speculate that a high concentration of calcium may strengthen
these intercellular junctions, thereby inhibiting malignant trans-
formation and growth. The same was observed in respect to fiber
intake. A high intake of fiber would result in higher concentra-
tions of butyrate. Butyrate is considered the first energy source
for colonocytes, because it stimulates normal cell growth but
inhibits tumor development, mainly by promoting cell apoptosis
(35). These antiproliferative and proapoptotic effects of fiber
consumption could somehow be amplified by the D1822V trait.
With the completion of the Human Genome Project, great op-
portunities exist to investigate the effects of genetic variation in the
host on the use and metabolism of nutrients. To our knowledge, this
is the first study performed in Southern Europe showing positive
interactions between well-known dietary promoters and protec-
tors of colorectal carcinogenesis and a polymorphism in the APC
gene. The ultimate goal of this investigation will be to enable the
provision of more precise public health advice about dietary
intake, supplement use, and genetic testing.
The authors’ responsibilities were as follows—CSG: design, subject eval-
uation, data collection, analysis, and manuscript preparation; MC: design,
subject evaluation, data collection, analysis, and manuscript preparation;
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authors had any financial or personal conflict of interest.
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